Assyro AI

Orange Book product · Generic (ANDA)

RIZATRIPTAN BENZOATE

RIZATRIPTAN BENZOATE

Generic (ANDA)ANDA 203062TE ABRX AUROBINDO PHARMA LTD
View RIZATRIPTAN BENZOATE familyOpen on FDA Orange Book

At a glance

Jul 01, 2013

Approved

Generic (ANDA)

Application

AB

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 01, 2013

    13 yr 2 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

RIZATRIPTAN BENZOATE

Strength

EQ 5MG BASE

Dosage form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

TE code

AB

Application

ANDA 203062

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of RIZATRIPTAN BENZOATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo